ABT
Abbott Laboratories
97.50$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +61.9% | -66.3% | +91.2% | +38.0% | +6.0% | -50.6% | +44.5% | +36.2% | +18.9% | -60.3% | +89.2% | – | |
| – | -1.3% | -1.0% | +0.0% | -0.5% | +0.7% | -6.3% | +2.8% | +1.8% | +0.1% | -7.8% | +38.8% | – | |
| – | -2.6% | +166.7% | -53.6% | -17.0% | -5.1% | +160.4% | -50.9% | -15.5% | -5.8% | +180.5% | -47.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -5,247.9% | – | – | – | +145.3% | -255.0% | – | – | |
| – | +34.8% | -47.3% | +33.9% | +4.3% | +29.5% | -32.8% | +3.7% | -1.2% | +38.9% | -42.1% | +0.0% | – | |
| – | +30.0% | -48.4% | +6.6% | +31.1% | +45.8% | -45.7% | +23.8% | -21.5% | +99.8% | +2,126.1% | -96.7% | – | |
| – | +0.0% | +7.8% | +0.4% | -0.1% | -0.2% | +7.1% | +0.3% | +0.2% | -0.1% | +6.6% | +0.4% | – | |
| – | -69.0% | -12.7% | -98.7% | +24,933.3% | -58.1% | -11.1% | -97.9% | +4,983.3% | -1.0% | -40.4% | +480.6% | – | |
| – | – | – | – | – | -1,525.6% | +69.0% | -98.6% | +3,186.7% | -85.8% | – | – | – | |
| – | -12.3% | -42.7% | -32.7% | +99.2% | +18.1% | +10.4% | -46.6% | +60.4% | -20.6% | – | -120.3% | – | |
| – | – | -427.3% | – | -18.8% | -89.8% | -1,969.0% | – | +33.7% | +80.5% | -270.0% | – | – | |
| – | +73.3% | -72.5% | +127.6% | +50.6% | 0.0% | -56.6% | +65.6% | +48.3% | +14.6% | -65.1% | +215.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.